Tim Bodicoat

Tim Bodicoat is a Science Writer for Cancer Research Horizons

Showing 3 out of 3 results

For Researchers

Minding the gap – what does China’s biotech boom mean for the UK?

China is emerging as a life sciences superpower - what does this mean for the UK’s researchers, spin-outs and patients? China is emerging as a life sciences superpower - what does this mean for the UK’s researchers, spin-outs and patients?

by Tim Bodicoat | Analysis | 2 March 2026

2 March 2026

This entry is part 2 of 2 in the series Minding the gap

For Researchers

Minding the gap – is there ever a perfect time to launch a start-up?

Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up… Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up…

by Tim Bodicoat | Analysis | 3 February 2026

3 February 2026

This entry is part 1 of 2 in the series Minding the gap

For Researchers

Making a startup out of a scientist

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

by Tim Bodicoat | Interview | 26 April 2023

26 April 2023

Cancer News

Tim Bodicoat

Minding the gap – what does China’s biotech boom mean for the UK?

Minding the gap – is there ever a perfect time to launch a start-up?

Making a startup out of a scientist